BridgeBio Pharma (BBIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

As the market hits record highs, investors can find stability in five low-leverage picks like NWG, CBOE, AA, SAFRY and CASY.

HCA (HCA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Sysco (SYY) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.09 per share a year ago.

Janus Henderson Group (JHG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Get a deeper insight into the potential performance of Enterprise Products (EPD) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

TriMas (TRS) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.43 per share a year ago.

Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Franklin Electric (FELE) came out with quarterly earnings of $1.3 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.17 per share a year ago.

Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Beyond analysts' top-and-bottom-line estimates for Crocs (CROX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Evaluate the expected performance of Republic Services (RSG) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Cirrus Logic (CRUS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Rithm (RITM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Helios Technologies (HLIO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Evaluate the expected performance of Alnylam (ALNY) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Ameriprise (AMP), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

The crude oil market has fallen again in the early hours of Tuesday, as we continue to see a lot of volatility out there. With this, the oil market sees a lot of selling pressure after the knee-jerk reaction to the Russian sanctions.

Get a deeper insight into the potential performance of Xcel (XEL) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.